Bossaerts Liene, Cacace Rita, Van Broeckhoven Christine
Neurodegenerative Brain Diseases Group, VIB Center for Molecular Neurology, Antwerp, Belgium.
Department of Biomedical Sciences, University of Antwerp - CDE, Universiteitsplein 1, B-2610, Antwerp, Belgium.
Mol Neurodegener. 2022 Apr 27;17(1):31. doi: 10.1186/s13024-022-00536-w.
Alzheimer's disease (AD) is the leading cause of dementia, clinically characterized by memory deficits and progressive cognitive decline. Despite decades of research effective therapies are lacking, and a large part of the genetic heritability remains unidentified. ABCA7 and ABCA1, members of the ATP-binding cassette subfamily A (ABCA), were identified as AD risk genes in genome-wide association studies. Nevertheless, genetic and/or functional studies propose a link between AD and two other members of the ABCA subclass, i.e., ABCA2 and ABCA5.
Changes in expression or dysfunction of these transporters were found to increase amyloid β levels. This might be related to the common role of ABCA transporters in cellular cholesterol homeostasis, for which a prominent role in AD development has been suggested. In this review, we provide a comprehensive overview and discussion on the contribution of the ABCA subfamily to the etiopathogenesis of AD.
A better understanding of the function and identification of disease-associated genetic variants in ABCA transporters can contribute to the development of novel therapeutic strategies for AD.
阿尔茨海默病(AD)是痴呆的主要病因,临床特征为记忆缺陷和进行性认知衰退。尽管经过数十年研究,但仍缺乏有效的治疗方法,且很大一部分遗传遗传性尚未明确。在全基因组关联研究中,ATP结合盒亚家族A(ABCA)的成员ABCA7和ABCA1被确定为AD风险基因。然而,遗传和/或功能研究表明AD与ABCA亚类的另外两个成员即ABCA2和ABCA5之间存在联系。
发现这些转运蛋白的表达变化或功能障碍会增加β淀粉样蛋白水平。这可能与ABCA转运蛋白在细胞胆固醇稳态中的共同作用有关,而细胞胆固醇稳态在AD发展中已被认为起重要作用。在本综述中,我们全面概述并讨论了ABCA亚家族对AD病因发病机制的贡献。
更好地了解ABCA转运蛋白的功能并鉴定与疾病相关的基因变异,有助于开发针对AD的新型治疗策略。